Future CAR T Therapy Research in Multiple Myeloma: Krina K. Patel, MD, MSc

Video

The associate professor from The University of Texas MD Anderson Cancer Center discussed future research with CAR T therapy in multiple myeloma.

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Subscribe Now!
Recent Videos
Tia DiTommaso, PhD, the senior director of preclinical pharmacology Arbor Biotechnologies, and John Murphy, PhD, the chief scientific officer of Arbor Biotechnologies
Annaiz Grimm, BS, a research scientist at Seattle Children's Research Institute.
Prerna Mewawalla, MD, medical director of Apheresis and a hematologist-oncologist in the Division of Hematology and Cellular Therapy at Allegheny Health Network, as well as an associate professor at the Drexel University College of Medicine.
Related Content
FDA Activity Recap: August 2025 Features Papillomatosis Gene Therapy Approval, Eli-Cel Labelling Update, and More

FDA Activity Recap: August 2025 Features Papillomatosis Gene Therapy Approval, Eli-Cel Labelling Update, and More

Noah Stansfield
September 3rd 2025
Article
ImmunoLogic Episode 5

ImmunoLogic, Episode 5: "Tumor Infiltrators and Triumphs: The Evolution of TIL Therapy" With Michael T. Lotze, MD

Joseph A. Fraietta, PhD;Michael T. Lotze, MD;Noah Stansfield;Matt Hoffman
September 3rd 2025
Podcast
Around the Helix: Cell and Gene Therapy Company Updates – August 27, 2025

Around the Helix: Cell and Gene Therapy Company Updates – August 27, 2025

Noah Stansfield
September 3rd 2025
Article
ImmunoLogic Episode 4

ImmunoLogic, Episode 4: "Inflammatory Storms and Gentle Balances: Navigating Toxicities in Immunotherapies" With Caroline Diorio, MD, FRCPC, FAAP

Joseph A. Fraietta, PhD;Janna Minehart, MD;Caroline Diorio, MD, FRCPC, FAAP;Noah Stansfield;Matt Hoffman
September 3rd 2025
Podcast
Surbhi Sidana, MD, an associate professor of medicine and associate director for Clinical Research in the Bone Marrow Transplantation and Cell Therapy Division at Stanford University

Cilta-Cel's Efficacy in Second-Line Relapsed/Refractory Multiple Myeloma

Surbhi Sidana, MD;Noah Stansfield
September 3rd 2025
Article
CGTLive®’s Weekly Rewind

CGTLive®’s Weekly Rewind – August 22, 2025

Noah Stansfield
September 3rd 2025
Article
© 2025 MJH Life Sciences

All rights reserved.